PARLODEL 2 1/2 017 017 (Bromocriptine Mesylate 2.5 mg)
Pill with imprint PARLODEL 2 1/2 017 017 is White, Round and has been identified as Bromocriptine Mesylate 2.5 mg. It is supplied by Ranbaxy Pharmaceuticals Inc..
Bromocriptine is used in the treatment of hyperprolactinemia; diabetes, type 2; acromegaly; parkinson's disease and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PARLODEL 2 1/2 017 017
- PARLODEL 2 1/2 017 017
- 2.5 mg
- 8.00 mm
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents, Prolactin inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- Inactive Ingredients
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|63304-0962||Ranbaxy Pharmaceuticals Inc.|
|30698-0202||Validus Pharmaceuticals LLC|
Related Images for "PARLODEL 2 1/2 017 017"
More about bromocriptine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 27 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- Patient Information
- Bromocriptine (Advanced Reading)
- Bromocriptine (Cycloset)
- Bromocriptine (Parlodel)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.